Journal article
A phase I study of oxidized raffinose cross-linked human hemoglobin
Abstract
OBJECTIVE: To evaluate the safety of oxidized-raffinose cross-linked human hemoglobin, Hemolink, in normal healthy volunteers.
DESIGN: Randomized, placebo-controlled, double-blind study.
Authors
Carmichael FJL; Ali ACY; Campbell JA; Langlois SF; Biro GP; Willan AR; Pierce CH; Greenburg AG
Journal
Critical Care Medicine, Vol. 28, No. 7, pp. 2283–2292
Publisher
Wolters Kluwer
Publication Date
7 2000
DOI
10.1097/00003246-200007000-00017
ISSN
0090-3493